The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-(3-(4-Bromobenzyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one ID: ALA4168388
PubChem CID: 145954816
Max Phase: Preclinical
Molecular Formula: C20H17BrN2O2S
Molecular Weight: 429.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2cccc(OCc3ccc(Br)cc3)c2)N=C2SCCCN12
Standard InChI: InChI=1S/C20H17BrN2O2S/c21-16-7-5-14(6-8-16)13-25-17-4-1-3-15(11-17)12-18-19(24)23-9-2-10-26-20(23)22-18/h1,3-8,11-12H,2,9-10,13H2/b18-12-
Standard InChI Key: WGRUZPUCMYXYQH-PDGQHHTCSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
24.0617 -5.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8812 -5.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2881 -4.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8808 -4.1555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0581 -4.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6508 -4.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1095 -4.8618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5220 -5.5737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3433 -5.5739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7484 -6.2865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5690 -6.2871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9827 -5.5748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5658 -4.8605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7466 -4.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9762 -4.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7975 -4.1488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2788 -4.8050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2744 -3.4787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0566 -3.7286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.0572 -4.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7639 -4.9571 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.4744 -4.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4738 -3.7275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7627 -3.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0179 -2.6987 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8294 -4.8658 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
15 16 2 0
16 17 1 0
17 20 2 0
19 18 1 0
18 16 1 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
18 25 2 0
6 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 429.34Molecular Weight (Monoisotopic): 428.0194AlogP: 4.70#Rotatable Bonds: 4Polar Surface Area: 41.90Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.74CX LogD: 4.74Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.66Np Likeness Score: -1.28
References 1. Schoeder CT, Kaleta M, Mahardhika AB, Olejarz-Maciej A, Łażewska D, Kieć-Kononowicz K, Müller CE.. (2018) Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18., 155 [PMID:29902723 ] [10.1016/j.ejmech.2018.05.050 ]